Small Bone Innovations, Inc., an orthopedics company focused exclusively on serving patients and their physicians with technologies and treatments for joint repair (arthroplasty) and trauma reconstruction around the small bones & joints of the thumb, fingers, hand, wrist, elbow, toes, foot and ankle, recorded strong worldwide revenue growth of 24% for 2010 compared with 2009.
Geographic gains were also robust. Revenues in North America grew by 33% year-on-year while revenues outside North America increased 14% in constant currency. North America represents approximately two-thirds of SBi’s total revenues while international revenues represent approximately one-third of total revenues, with France as the largest market. SBi’s 2010 revenues were evenly split between the upper limb and lower limb.
Anthony G. Viscogliosi, Chairman & CEO of SBi, said, “I am very pleased to report the company’s significant revenue growth in 2010. This performance is especially noteworthy given the fact that global orthopedic device revenue growth continued to slow throughout last year as elective surgeries declined due to the soft economy.”
Small Bone Innovations, Inc. was founded in 2004 by Viscogliosi Brothers, LLC, a New York-based merchant banking firm that specializes in the musculoskeletal/orthopedics sector. VB created SBi as the first company to focus purely on small bones & joints. By integrating established companies and professionals in the field, SBi offers a broad, clinically proven portfolio of products and technologies to treat trauma and diseases in small bones & joints. Today, SBi has facilities in New York, NY, Morrisville, PA, Bourg-en-Bresse, France, Donaueschingen, Germany, and Kuala Lumpur, Malaysia and has sold its products in 46 countries.